InvestorsHub Logo

matt24d

09/25/14 12:21 PM

#326049 RE: maytepper #326047

RNN here is the part I liked on that read

The company has previously stated that it is engaged in partnering discussions for ‘3117, and we believe that both the data readout from the dose escalation study and the granting of Orphan Designation could potentially catalyze these discussions.”